Ambu A/S

Price Chart

Risk-Adjusted Performance

Also Listed On

Ambu A/S (AMBBY) Price Performance

Ambu A/S (AMBBY) trades on United States in USD. The company is classified in the Healthcare sector under the Medical Devices industry. The stock currently trades at $10.60, down 1.12% from the previous close.

Over the past year, AMBBY has traded between a low of $10.60 and a high of $17.69. The stock has lost 37.6% over this period. It is currently 40.1% below its 52-week high.

Ambu A/S has a market capitalization of $2.99B, with a price-to-earnings ratio of 34.72 and a dividend yield of 3.69%.

About Ambu A/S

Ambu A/S, together with its subsidiaries, researches, develops, manufactures, markets, and sells medical technology solutions in North America, Europe, and internationally. The company offers endoscopy products, including bronchoscopes, video laryngoscopes, rhinolaryngoscopes, duodenoscopes, gastroscopes, cystoscopes, ureteroscopes, and displaying and processing units; neurology products, such as EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products; and cardiology products comprising ECG electrodes. It also provides airway management and anaesthesia products, which include double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers emergency care and training products, such as extrication collars and ALS and BLS training manikins, as well as mobile workstations, IOMs, and patient monitoring and diagnostics devices. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.